Victory Capital Management
XTNT icon

Victory Capital Management’s Xtant Medical Holdings XTNT Stock Holding History

Victory Capital Management’s Portfolio XTNT Stock Details XTNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-12,154
Closed -$8K – 2756
2022
Q1 		$8K Sell
12,154
-347
-3% -$227 ﹤0.01% 2688
2021
Q4 		$7K Sell
12,501
-375
-3% -$353 ﹤0.01% 2749
2021
Q3 		$14K Sell
12,876
-650
-5% -$845 ﹤0.01% 2745
2021
Q2 		$22K Buy
13,526
+1,013
+8% +$1.8K ﹤0.01% 2705
2021
Q1 		$30K Buy
12,513
+562
+5% +$1.2K ﹤0.01% 2702
2020
Q4 		$14K Buy
+11,951
New +$15.4K ﹤0.01% 2512
2020
Q2 		– Sell
-2,189
Closed -$1K – 3312
2020
Q1 		$1K Buy
+2,189
New +$2.64K ﹤0.01% 3655
2019
Q4 		– Sell
-2,246
Closed -$6K – 3303
2019
Q3 		$6K Buy
+2,246
New +$6.24K ﹤0.01% 3418

Other funds holding XTNT

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $510M AUM 49.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Victory Capital Management's XTNT Position: Q2 2022 in Review

Victory Capital Management sold out of Xtant Medical Holdings (XTNT) in Q2 2022, closing a stake of 12,154 shares — an estimated $8K sold.

Victory Capital Management first reported a position in XTNT in Q3 2019 and held it in 8 quarters. The position peaked at $30K in Q1 2021. 18 funds tracked by Wall St. Rank hold XTNT as of Q2 2022.

  • Victory Capital Management reported no remaining Xtant Medical Holdings position as of Q2 2022 after selling out during the quarter.
  • Victory Capital Management sold 12,154 Xtant Medical Holdings shares in Q2 2022, an estimated $8K.
  • Victory Capital Management first reported a position in Xtant Medical Holdings in Q3 2019 and held it in 8 quarters.
  • Victory Capital Management's Xtant Medical Holdings position peaked at $30K in Q1 2021.
  • 18 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q2 2022.

Based on Victory Capital Management's 13F filing for Q2 2022, filed 1 Aug 2022.